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Abstract 
The World Health Organization (WHO) is currently revisiting the International 
Classification of Diseases and related health problems (ICD). In the tenth version of 
the ICD, approved in 1990, hypochondriacal symptoms are described in the context 
of both the primary condition Hypochondriacal Disorder, and as secondary 
symptoms within a range of other mental disorders. An expanding research base 
since 1990 makes a critical evaluation and revision of both the definition and 
classification of Hypochondriacal Disorder timely. This paper addresses the 
considerations reviewed by members of the WHO working group on obsessive-
compulsive and related disorders in their proposal for the description and 
classification of Hypochondriasis (Illness Anxiety Disorder). The proposed revision 
emphasizes the phenomenological overlap with both anxiety disorders (e.g., fear, 
hypervigilance to bodily symptoms, and avoidance) and obsessive-compulsive and 
related disorders (e.g., preoccupation and repetitive behaviours) and the distinction 
from the somatoform disorders (presence of somatic symptom is not a critical 
characteristic). The revision aims at better recognition and treatment of patients with 
Hypochondriasis within the broad range of global health care settings. 
 
Key words 
Hypochondriasis, illness anxiety disorder, obsessive-compulsive and related 
disorders, definition, classification 
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Introduction 
 
The World Health Organization (WHO) is currently revisiting the International 
Classification of Diseases and related health problems (ICD). The tenth version of 
the ICD was approved in 1990 (WHO, 1992),1 almost 25 years ago. The revision to 
ICD-11 requires attention to the relevant historical background as well as to more 
recent developments in understanding of clinical entities related to illness 
preoccupation and fear. This paper addresses the question of how hypochondriasis 
should be described and classified in the ICD-11, and addresses the considerations 
reviewed by the members of the WHO working group on obsessive-compulsive and 
related disorders in their proposal for the description and classification of this 
disorder.  
 
Preoccupation with bodily symptoms and fear of suffering from a serious disease 
falls on a continuum ranging from a very mild concern about some unusual bodily 
sensation or observation to severe pr occupation and fear or conviction in individuals 
in whom thoughts and actions are cente ed around the over-estimated risk of having 
or getting a serious life-threatening illness.2 Taxometric studies have empirically 
confirmed that health anxiety is a dimensional rather than a categorical construct.3,4 
Normal expressions of concern about health and alertness towards bodily symptoms 
may be a useful response to changes in the body that are caused by medical 
conditions and that warrant medical evaluation and/or treatment. Certainly, from an 
evolutionary perspective an appropriate level of anxiety and responding to somatic 
alarm symptoms may have adaptive value. However, when the concern about health 
becomes a matter of preoccupation and continuous fear or distress, it interferes with 
daily life.  
Individuals with such concerns may meet the criteria for the DSM-IV-TR and 
ICD-10 diagnoses of hypochondriasis and hypochondriacal disorder, respectively. 
Severe hypochondriasis has negative impacts on quality of life, social and 
occupational functioning, and health care resource utilization, and is thus a relevant 
mental disorder to recognize and treat in clinical practice. Although health care 
practitioners are familiar with those  patients who seek reassurance during repeated 
visits to health care services, resulting in high health care costs, unnecessary 
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diagnostic interventions and disturbed patient-doctor relationships, hypochondriasis 
can also lead to severe avoidance, risking unfavorable patient delay in case of actual 
diseases. In most patients with hypochondriasis, symptoms wax and wane, with acute 
exacerbations triggered by stressful periods, due to e.g. a loss of a family member, a 
past experience of actual organic disease, and social circumstances, or in response to 
hospital and disease-related items on popular media.5 
 
Historical background 
 
Hypochondriasis as a psychiatric concept and diagnosis has been the subject of 
considerable controversy over the centuries. Today, hypochondriasis is considered a 
mental disorder, but in the seventeenth century it referred to a common somatic 
condition, with the name ‘hypochondria’, introduced by Hippocrates and literally 
meaning ‘below the cartilage’, and suggesting the involvement of abdominal organs. 
The transformation of the description over time, with the initial reference to the 
mental condition in the early nineteenth century, has been described extensively by 
Noyes.6 In short, summarizing this historical overview, in the seventeenth century 
authors, still strongly influenced by Galen’s views of pathogenesis, related 
hypochondriasis to melancholic personality traits, caused by somatic digestive 
disturbances. Psychological concepts became more prominent in the description of 
hypochondriasis from the late eighteenth century. At that time it was thought that a 
depressive ‘morbid’ state changes the body awareness, resulting in digestive 
disturbances. Although attention started to switch from the intestines to the brain at 
that time, hypochondriasis became regarded as a neurosis, i.e., a functional rather 
than structural disturbance. Fear of serious illness was emphasized as principle 
characteristic, the presence of digestive symptoms were no longer considered as 
crucial, and the bodily preoccupation and hypervigilance and the abnormal illness 
behaviors started to receive attention. During this ‘physical-to-mental’ transformation 
of the concept of hypochondriasis, it became one of many mental disorders. The 
historical review by Noyes, mainly focusing on the 17th, 18th and 19th century, shows 
the influential role of social and cultural factors in shaping the description of the 
disorder over time, and the uncertainty about how to classify the disorder in relation 
to other clinical entities. 
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 Psychodynamic theories of hypochondriasis mainly focused on the role of 
(unconscious) guilt over sexual and hostile wishes, fantasies and feelings that must 
be disguised to avoid overwhelming fear of punishment, bodily damage (castration) 
and death.7 The psychodynamic term ‘hypochondriacal neurosis’ was adopted by 
DSM-II, and despite criticism and controversy of both the relevant terminology and 
construct, the term ‘hypochondriasis’ and ‘hypochondriacal disorder’ persisted in 
subsequent revisions of DSM and ICD.8  
 Current concepts of hypochondriasis have been considerably influenced by 
cognitive-behavioral approaches.2 Salkovskis and Warwick, for example, have 
suggested that the preoccupation with (ill) health is the key cognitive component and 
the seeking of reassurance from physicians as well as repeated checking of the body 
is the most crucial behavioural component. They put forward the idea that repetitive 
reassurance seeking is a form of avoidance which serves to maintain the 
preoccupation with health, just as compulsions increase the impact of obsessions and 
distress over the long-term in patients with obsessive-compulsive disorder (OCD).9,10 
Since medical reassurance results in immediate relief followed by the longer-term 
return of anxiety, they proposed that these avoidance behaviors are important 
maintaining factors and a major focus for treatment. Their case reports indicate that 
treatments focused on elimination of reassurance (response prevention) and 
facilitation of self-directed exposure and cognitive change (cognitive reappraisal) are 
successful in the reduction of discomfort and attenuation of the urge to seek 
reassurance on the long-term. 
 The long-lasting debate on both the terminology and the conceptualization of 
hypochondriasis is currently focused on the following issues:11 1) is hypochondriasis 
a distinct primary medical entity or a secondary feature of other psychopathologies? 
2) what are the discriminating diagnostic features of hypochondriasis and how can 
these be differentiated from normality? and 3) how to classify hypochondriasis taking 
into account its relation to somatoform disorders, anxiety disorders and obsessive-
compulsive and related disorders? Here we summarize the existing but limited 
literature on these issues, recent developments in relation to DSM-5, and propose the 
options for ICD-11. 
 
The ICD-10 approach to hypochondriasis 
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In the ICD-10 (WHO, 1992)1 hypochondriacal symptoms are described in the context 
of both the primary condition hypochondriasis, and as secondary symptoms of a 
range of other mental entities (e.g., delusional disorder, and depression). As primary 
entities within the category of somatoform disorders, F45.2 Hypochondriacal 
Disorders represent five related and partly overlapping sub-entities, i.e., body 
dysmorphic disorder (BDD), dysmorphophobia, hypochondriacal neurosis, 
hypochondriasis and nosophobia. The main characteristics of hypochondriacal 
disorder in ICD-10 concern 1) the persistent belief in the presence of at least one 
serious physical illness underlying the presenting symptom(s), even though repeated 
investigations and examinations have identified no adequate physical explanation, or 
a persistent preoccupation with a presumed deformity or disfigurement; and 2) the 
persistent refusal to accept the advice and reassurance of several different doctors 
that there is no physical illness or abnormality underlying the symptoms.  
Based on more recent res arch,2 some aspects related to the definition of the 
clinical entity, the relationship to related conditions, and the classification within the 
somatoform category need to be reconsidered. First, the presence of a physical 
symptom is not crucial for the diagnosis of hypochondriasis, since in many cases 
preoccupation with or fear for a serious illness exists without actual somatic 
symptoms.12 Second, patients with hypochondriasis seek out reassurance and are 
happy to learn that there is no immediate threat (in contrast to most patients with 
other somatoform disorders who seek a diagnosis and keep on seeking to get one), 
but fail to maintain the immediate feeling of relief after medical reassurance, due to 
the recurrent preoccupation or concern and return of fear, resulting in avoidance or 
repetitive reassurance seeking or other repetitive behaviors.13 Although checking 
behaviors and reassurance seeking give some relief, the reduction in fear is 
transient.14 Some patients predominately experience repetitive behaviors, whereas 
other patients mainly show strong avoidance or switch between avoidance and 
checking behaviors over time. 
 In the DSM-IV-TR (APA, 2000)15, hypochondriasis and BDD are separate 
entities within the category of somatoform disorders. This is consistent with the 
growing literature indicating that BDD is a distinct entity with diagnostic validity and 
clinical utility.16 The diagnostic criteria for hypochondriasis in DSM-IV include the 
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preoccupation with or fear for a serious disease, based on the person’s 
misinterpretation of bodily symptoms.2 DSM-IV also includes a minimal duration of 
six months and an optional specifier ‘poor insight’, for patients who do not recognize 
that the concern is excessive or unreasonable.  
 In the context of current diagnostic classification in DSM-IV-TR and ICD-10, 
and now also DSM-5 (see below), hypochondriasisis is considered a somatoform 
disorder,1,12,15 but it has always been at the crossroads of different categories. The 
fact that the presence of somatic symptoms is not a diagnostic criterion for 
hypochondriasis is inconsistent with the classification within the somatoform 
disorders. Moreover, since the key clinical features (preoccupation, anxiety, bodily 
hypervigilance and avoidance behaviors) and the most effective treatment strategy 
(cognitive behavior therapy, mostly including exposure in vivo with response 
prevention) in hypochondriasis largely overlap with those in anxiety disorders as 
panic disorder, social anxiety disorder, generalized anxiety disorder, and obsessive-
compulsive disorder (OCD), classification within the Anxiety Disorders category or 
the Obsessive-Compulsive and Related Disorders category would be more consistent 
with the more recent conceptualizations of the disorder.2 
 
- add Table 1 here - 
 
Illness anxiety disorder and somatic symptom disorder in DSM-5 
 
In DSM-5 hypochondriasis appeared, within the category of Somatic Symptom and 
Related Disorders (formerly known as somatoform disorders), partly as illness 
anxiety disorder and partly as somatic symptom disorder.12 The common feature of 
the Somatic Symptom and Related Disorders is the prominence of somatic symptoms 
associated with significant distress and impairment. The category consists of somatic 
symptom disorder, illness anxiety disorder, conversion disorder, psychological 
factors affecting other medical conditions, factitious disorders, other specified 
somatic symptom and related disorders, and unspecified somatic symptom and 
related disorder. Depending on the symptoms of the individual, and particular the 
presence or absence of somatic symptoms, the patient that would have been 
diagnosed as hypochondriasis in the DSM-IV-TR, will now be diagnosed as illness 
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anxiety disorder (where somatic symptoms are absent or only mild) or as somatic 
symptom disorder (where one or more somatic symptoms are distressing or result in 
significant disruption of daily life). Within the illness anxiety disorder entity, two 
specifiers have been defined, a care-seeking type with high health care utilization and 
a care-avoidant type. Where the definition of the illness anxiety disorder is specific 
and includes a cognitive component (preoccupation), an affective component 
(substantial anxiety), and a behavioral component (care-avoidant and care-seeking 
health-related behaviors), the definition of somatic symptom disorder is broader 
(‘thoughts, feelings and behaviors related to present somatic symptoms’). The 
definition of illness anxiety disorder does not include the feature ‘hypervigilance to 
bodily symptoms’ as a diagnostic criterion, but mentions that ‘the individual is easily 
alarmed about personal health status’. It also includes a criterion on the differential 
diagnosis with other disorders, such as somatic symptom disorder, panic disorder, 
generalized anxiety disorder, body dysmorphic disorder, obsessive-compulsive 
disorder, or delusional disorder, somatic type. Both entities include a duration 
criterion, of at least 6 months, to underline the chronicity of the disorders. No insight 
specifiers have been defined for illness anxiety disorder and somatic symptom 
disorder, in contrast to some related disorders, e.g., OCD, BDD. 
 Apart from the potential risk of the overlapping criteria of the somatic 
symptom disorder and the illness anxiety disorder, it is notable that DSM-5 kept 
hypochondriasis with the category of Somatic Symptom and Related Disorders 
instead of moving it to the Anxiety Disorders category or the Obsessive-Compulsive 
and Related Disorders category.  
 
Considerations for ICD-11 
 
Phenomenology 
We propose the following definition of the phenotype: illness anxiety disorder refers 
to a persistent preoccupation with or fear about the possibility of having one or more 
serious progressive or life-threatening diseases. The preoccupation is associated with 
a hypervigilance to and catastrophic misinterpretation of bodily signs or symptoms, 
including normal or commonplace sensations, and is accompanied by avoidance 
and/or repetitive behaviours. The preoccupation and/or fear is not simply a 
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reasonable concern related to a specific context of the patient, it persists or reoccurs 
despite appropriate medical evaluation and reassurance and causes clinically 
significant distress or impairment in important areas of functioning. 
As the definition indicates, the phenotype is characterized by four main 
domains of dysfunction: preoccupation and misinterpretation (cognitive component), 
fear/anxiety (affective component), hypervigilance to bodily symptoms (attentional 
component), and avoidance and repetitive behaviours (behavioural component). The 
preoccupations show overlap with  worries in patients with generalized anxiety 
disorder (GAD),17,18 but in GAD the concerns have a more general content, often 
related to daily activities and there are also a range of other concerns. The 
preoccupations also show overlap with the obsessions in OCD,19,20 but the important 
difference is that in hypochondriasis the thoughts are only related the concern of 
having or getting a serious illness. Hypervigilance to and catastrophic 
misinterpretation of bodily signs or symptoms is also present in patients with panic 
disorder, but panic attacks are a core feature of panic disorder.21 In some cases of 
hypochondriasis where the illness concerns are mainly related to the cardiovascular 
system, differentiation between hypochondriasis and panic disorder might be 
difficult. Avoidance and repetitive safety-seeking behaviours (e.g., checking body, 
information seeking, reassurance seeking) are common in patients with OCD22 and 
BDD23 as well. Although the phenotype of hypochondriasis shows little overlap with 
somatoform disorders, some patients with hypochondriasis often present with 
somatic symptoms. In these patients, in contrast to somatoform patients, it is not the 
physical symptoms that are the main reason for distress and disability, but rather the 
concern about such symptoms. 
Some comparative studies have been published on the phenomenological and 
neurobiological overlap and differentiation between hypochondriasis, panic disorder 
and OCD.24-26 These studies show that hypochondriasis shares characteristics with 
both disorders (panic attacks, obsessions, compulsions, attentional bias to disorder-
specific or threat-related information, and aberrant recruitment of fronto-striatal and 
limbic brain circuits), yet also indicate that hypochondriasis is a separate entity.  
 In most patients with hypochondriasis, symptoms wax and wane over time. 
Both the behaviours and associated insight can change significantly during the course 
of the disorder. Also, in the case of poor insight, it is important to diagnose 
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hypochondriasis (illness anxiety disorder), from delusional or psychotic disorder, 
since this distinction has important clinical implications. Although most of the 
relevant literature is based on patients with delusional and non-delusional body 
dysmorphic disorder, it shows more similarities than differences (also related to 
response to pharmacology),27 and one might expect the same issues to arise in 
hypochondriasis.  
 
Classification 
Hypochondriasis is a separate diagnostic  entity that lies exactly at the crossroads of 3 
categories, showing overlap with somatoform disorders (in DSM-5 now called 
somatic symptom and related disorders), anxiety disorders, and obsessive-compulsive 
and related disorders. Since a mental disorder can only be classified under one 
primary category, the decision on which category fits best is always a compromise.  
The least optimal classification is among the somatoform disorders. Although 
classification with the somatoform disorders might be intuitive for those patients who 
present with many somatic symptoms, there are three reasons to change the existing 
approach. First, in many patients with hypochondriasis no or only mild somatic 
symptoms are present, and if present the interference with daily functioning is not 
resulting from the somatic distress or disability but is rather the consequence of the 
fear about the symptoms and the related behaviour. Second, patients with 
hypochondriasis are eager to find reassurance that nothing serious is happening in 
their body (although the reassurance only results in transient relief of distress and 
may maintain the preoccupation over the long-term), patients with other somatoform 
disorders wish a diagnosis. Third, the therapeutic approach differs from the treatment 
of most somatoform disorders but largely overlaps with most anxiety disorders: 
cognitive behavior therapy, including exposure in vivo with response prevention.28  
In the process of moving hypochondriasis to a category with more related 
disorders, two good alternatives exist. Most key characteristics of hypochondriasis, 
i.e., anxiety, hypervigilance to and catastrophic misinterpretation of bodily 
symptoms, and avoidance strongly resemble the phenotype of other anxiety 
disorders, mainly panic disorder.26 In 2 comparative brain imaging studies on 
attentional bias24 and executive functioning25 in OCD, panic disorder and 
hypochondriasis, the task-related neural activation patterns showed both overlap and 
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differentiation between the disorders. Gropalis et al. (2012) compared 65 patients 
with hypochondriasis, 94 patients with somatoform disorders (including somatization 
disorder, undifferentiated somatoform disorder and pain disorder), and 224 patients 
with anxiety disorders (including panic disorder with/without agoraphobia, GAD and 
OCD) regarding demographic variables, clinical features and naturalistic treatment 
outcomes. They found a closer connection between hypochondriasis and anxiety 
disorders than between hypochondriasis and somatoform disorders.29 
Given the repetitive characteristics of hypochondriasis, both cognitive (i.e., 
preoccupation) and behavioral (i.e., compulsive checking of the body and internet, 
repetitive seeking for reassurance from health professionals), the overlap with 
OCD20,30 and BDD16, which will be categorized as obsessive-compulsive and related 
disorders, classification of hypochondriasis with these disorders might be an 
alternative option. Considering the fact that BDD and hypochondriasis were 
diagnosed together as hypochondriacal disorder in ICD-10, the most conservative 
approach would be to keep both disorders in the same category; the obsessive-
compulsive and related disorders, which in turn are closely related to the anxiety 
disorders. Since hypochondriasis shares symptoms with OCD30 and responds to the 
same treatments (cognitive behaviour therapy and serotonergic antidepressants),31,32 
classification within the obsessive-compulsive and related disorders category adds to 
the clinical utility of the classification system. Although the same arguments hold for 
the overlap with other anxiety disorders, justifying a 2nd parent classification of 
hypochondriasis among the anxiety disorders, it’s not the case for the somatoform 
disorders. 
 
Terminology 
Not only has the conceptualization of hypochondriasis been a matter of debate for 
centuries, but also the name ‘hypochondriasis’ has been controversial for decades, due 
to its potentially confusing and pejorative aspects. Depending on the 
conceptualization of the disorders, alternative terms have been proposed during the 
last 3 decades: ‘abnormal illness behaviour’,33 ‘disease phobia’,34 ‘illness phobia’,35 
‘health anxiety’,2,36 ‘specific phobia for illness’,37 ‘illness preoccupation disorder’,11 
‘heightened illness concern’ (Fallon scale), and now in DSM-5 ‘illness anxiety 
disorder’ and ‘somatic symptom disorder’. Considering the main characteristics of the 
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disorder, illness anxiety disorder or illness preoccupation disorder would be 
reasonable alternatives for the term ‘hypochondriasis’. Although the term 
“hypochondriasis” has some archaic and pejorative elements, the phrase “illness 
anxiety” may not be easily translated across all languages, and it seems odd to 
categorize an “anxiety disorder” primarily in a chapter other than the anxiety 
disorders. A compromise is to maintain the name “Hypochondriasis”, but to include 
in parenthesis the term “illness anxiety disorder”. This is consistent with a 2nd parent 
classification of hypochondriasis among the anxiety disorders and would also 
maintain continuity with DSM-5.   
 
Conclusion 
For the revision of the ICD-10, we propose that hypochondriasis will be classified as 
illness anxiety disorder within the category of obsessive-compulsive and related 
disorders. Illness anxiety disorder is defined as a persistent preoccupation with or fear 
about the possibility of having one or more serious progressive or life-threatening 
diseases, accompanied by hypervigilance to and catastrophic misinterpretation of 
bodily signs or symptoms, including normal or commonplace sensations, resulting in 
both avoidance and reassurance-seeking behaviours, persisting or reoccurring despite 
medical evaluation and reassurance. The definition shows considerable overlap with 
anxiety disorders and obsessive-compulsive and related disorders. Classification 
among the obsessive-compulsive and related disorders, with a 2nd parent classification 
among the anxiety disorders, will improve the recognition of the disorder and 
encourage the use of appropriate treatments within the broad range of global health 
care settings. Finally we propose that the insight specifier for hypochondriasis be 
similar to that used for OCD and BDD. 
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 ICD-101 DSM-IV-TR15 DSM-512 ICD-11 (proposal) 
Category Somatoform Disorders Somatoform Disorders  Somatic Symptom and Related 
Disorders 
Primary category: Obsessive-
Compulsive and Related Disorders 
Secondary category: Anxiety Disorders 
Name Hypochondriacal Disorder (F45.2) Hypochondriasis (300.7) Illness Anxiety Disorder (300.7) Hypochondriasis (Illness Anxiety 
Disorder) 
Diagnostic criteria A. Persistent belief in the presence of at 
least one serious physical illness 
underlying the presenting 
symptom(s), even though repeated 
investigations and examinations have 
identified no adequate physical 
explanation  
or: 
persistent preoccupation with a 
presumed deformity or disfigurement. 
B. Persistent refusal to accept the 
advice and reassurance of several 
different doctors that there is no 
physical illness or abnormality 
underlying the symptoms 
A. Preoccupation with fears of having, 
or the idea that one has, a serious 
disease based on the person's 
misinterpretation of bodily symptoms 
B. The preoccupation persists despite 
appropriate medical evaluation and 
reassurance. 
C. The belief is not of delusional 
intensity (as in Delusional Disorder, 
Somatic Type) and is not restricted to a 
circumscribed concern about 
appearance (as in Body Dysmorphic 
Disorder)  
D. The preoccupation causes clinically 
significant distress or impairment in 
social, occupational, or other important 
areas of functioning. 
E. The duration of the disturbance is at 
least 6 months. 
F. The preoccupation is not better 
accounted for by Generalized Anxiety 
Disorder, Obsessive-Compulsive 
Disorder, Panic Disorder, Major 
Depressive Disorder, Separation 
Anxiety, or another Somatoform 
Disorder 
A. Preoccupation with having or 
acquiring a serious illness 
B. Somatic symptoms are not present 
or, if present are only mild in intensity. 
If another medical condition is present 
or there is a high risk for developing a 
medical condition, the preoccupation is 
clearly excessive or disproportionate 
C. High level of anxiety about health, 
and the individual is easily alarmed 
about personal health status 
D. Excessive health-related behaviors 
or maladaptive avoidance 
E. Symptom duration at least 6 months 
F. Not better explained by another 
mental disorder 
A. Persistent preoccupation with or fear 
about the possibility of having one or 
more serious progressive or life-
threatening diseases 
B. The preoccupation is associated with 
a hypervigilance to and a catastrophic 
misinterpretation of bodily signs or 
symptoms, including normal or 
commonplace sensations 
C. The preoccupation or fear is not 
simply a reasonable concern to a 
specific context of the patient and it 
persists or reoccurs despite appropriate 
medical evaluation and reassurance 
D. One or more of the following 
behaviours occur in relation to the 
preoccupation or fear: avoidance, 
checking, information seeking, and/or 
requests for reassurance 
E. The preoccupation or fear causes 
clinically significant distress or 
impairment in important areas of 
functioning 
F. The diagnosis also includes those 
with no insight or with delusional 
beliefs 
Includes Body Dysmorphic Disorder 
Dysmorphophobia (nondelusional) 
Hypochondriacal Neurosis 
Hypochondriasis 
Nosophobia 
   
Specifiers  Poor insight Care-seeking type 
Care-avoidant type 
No insight 
 
Page 18 of 18
http://mc.manuscriptcentral.com/rbp
Revista Brasileira de Psiquiatria
